Catalent Australia and Medipharm Partner to Supply Malaysian Market with Three New Health Care Products
Braeside, Australia, March 20, 2013 – Catalent Pharma Solutions today announced that it will apply its drug delivery technology for the launch of three new products for Malaysian natural healthcare supplier, Medipharm Industries. Catalent has worked together with Medipharm to quickly develop superior new formulations for Medipharm’s recently launched Eurobio Vibrex Zinc-Plus, Bio-Vizmax and Bio-SMEDDS Q10 products for the Malaysian market and will now act as sole supply partner.
Eurobio Vibrex Zinc-Plus is an advanced formula containing zinc and other essential nutrients designed to provide complete support for skin, hair and nail health, men’s health, immunity and vitality. Bio-Vizmax provides eye nutrition and is formulated with clinically tested Lutein and Zeaxanthin for eye/vision health, while Bio-SMEDDS CoQ10 is being marketed to general practitioners and cardiologists in 50mg capsules for heart health and organ function. Catalent manufactures the products at its Braeside facility, near Melbourne, Australia. All products are manufactured to the highest cGMP and cGLP pharmaceutical standards.
“Catalent’s expertise in optimized formulation for the effective delivery of our products has enabled us to get these three new offerings to market quickly and efficiently,” commented Medipharm Managing Director, CM Loh. “This was particularly useful in the case of Bio-SMEDDS Q10, where the enhanced bioavailability that Catalent was able to bring gives us a significant differentiating advantage over other CoQ10 formulations on the market.”
“Our expertise is all about helping our partners get better products to market faster,” commented Michele Stokes, Strategy and Business Development Director at Catalent’s Braeside facility. “With a total population of over 28 million, almost 65% of whom are aged between 15 and 64 years old,* Malaysia offers significant growth opportunities for companies involved in the health care business and we are pleased to be working with Medipharm on these important products.”
Medipharm is an emerging and dynamic organization with the vision of advancing overall quality of life through its trusted quality products and high standard of quality service. Medipharm’s portfolio of brands offers research-based nutritional supplements manufactured according to stringent regulatory standards and incorporating scientifically supported high quality pharmaceutical ingredients and packaging. Backed by a wealth of experience from a strong team of technical specialists with vast areas of expertise, Medipharm continuously develop new formulations and line extensions to bring latest innovative healthcare solutions to the community. For more information, visit www.medipharm.com.my.
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 9,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com.